ZWS insider files Form 144 to sell 20,349 shares on NYSE
Rhea-AI Filing Summary
Zurn Elkay Water Solutions (ZWS) filed a Form 144 reporting a proposed sale of 20,349 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $944,934.30. The filing shows the shares were initially granted as restricted stock: 14,788 acquired 12/29/2021 and 5,561 acquired 05/13/2022. The filer also reported a sale on 07/31/2025 of 22,138 shares for gross proceeds of $953,060.82. The filing states that the person represents they have no undisclosed material nonpublic information. Outstanding common shares noted in the form total 167,552,517, and the proposed sale date is 08/27/2025.
Positive
- Timely disclosure of a proposed insider sale including exact share counts, acquisition dates, and aggregate value.
- Transaction transparency: filing identifies broker (Morgan Stanley Smith Barney) and exchange (NYSE) and includes prior recent sale details.
Negative
- Insider selling activity occurred recently (22,138 shares sold on 07/31/2025) and another sale is proposed (08/27/2025), which may merit monitoring by investors.
Insights
TL;DR: Routine insider sale disclosure; size is small relative to float and likely neutral for valuation.
The Form 144 documents a proposed sale of 20,349 shares valued at about $945k and a prior sale of 22,138 shares in July 2025. Compared with the reported outstanding share count of 167.6 million, the proposed sale represents roughly 0.012% of shares outstanding, indicating limited direct market impact. The securities were granted as restricted stock in 2021 and 2022, suggesting this is an executive or employee liquidity event rather than a corporate financing. The filing complies with Rule 144 disclosure requirements and the signer affirms no material nonpublic information.
TL;DR: Disclosure is consistent with governance best practices; repeated sales warrant monitoring but are not material alone.
The report shows timely disclosure of an intended sale and documents the acquisition dates and form of issuance (restricted stock). From a governance perspective, the signer’s attestation of no undisclosed material information is standard and important. The presence of a prior July sale followed by a proposed August sale may reflect a planned selling pattern or liquidity needs under trading plans; the filing itself does not state a 10b5-1 plan. No indications of irregularities are present in the document provided.